Gonococcal conjunctivitis is a serious eye infection caused by the bacteria Neisseria gonorrhoeae. It is also known as gonorrhea of the eye, and can cause severe inflammation and pain. If left untreated, it can lead to serious complications, including blindness. In this article, we will take a closer look at gonococcal conjunctivitis, including its causes, symptoms, and treatment options.
Gonococcal conjunctivitis is an infection of the eye caused by the bacteria Neisseria gonorrhoeae. It is a sexually transmitted disease, and is most commonly spread through sexual contact. It can also be spread through contact with infected secretions, such as semen or vaginal fluid. It can also be spread through contact with contaminated objects, such as towels or bedding. Gonococcal conjunctivitis can affect both eyes, but is more commonly seen in one eye. It is most common in adults, but can also affect children and infants.
The most common symptom of gonococcal conjunctivitis is redness of the eye. Other symptoms may include pain, itching, discharge, and swelling. In some cases, the infection can cause blurred vision or sensitivity to light.
Gonococcal conjunctivitis is caused by the bacteria Neisseria gonorrhoeae. This bacteria is spread through sexual contact or contact with infected secretions, such as semen or vaginal fluid. It can also be spread through contact with contaminated objects, such as towels or bedding.
The risk of developing gonococcal conjunctivitis increases with certain behaviors and conditions. These include: • Having unprotected sex • Having multiple sexual partners • Having a history of sexually transmitted infections • Having a weakened immune system • Having contact with an infected person
Gonococcal conjunctivitis is diagnosed through a physical examination and laboratory tests. During the physical exam, the doctor will check for signs of infection, such as redness, swelling, and discharge. The doctor may also take a swab of the discharge to test for the presence of the bacteria Neisseria gonorrhoeae.
Gonococcal conjunctivitis is treated with antibiotics. These antibiotics can be taken orally or applied topically to the eye. It is important to follow the doctor’s instructions carefully and finish all of the medication, even if the symptoms have improved.
The best way to prevent gonococcal conjunctivitis is to practice safe sex and to avoid contact with infected secretions or contaminated objects. It is also important to get tested for sexually transmitted infections regularly.
Gonococcal conjunctivitis is a serious eye infection caused by the bacteria Neisseria gonorrhoeae. It is most commonly spread through sexual contact or contact with infected secretions. It can cause severe inflammation and pain, and can lead to serious complications if left untreated. The best way to prevent gonococcal conjunctivitis is to practice safe sex and to avoid contact with infected secretions or contaminated objects. Treatment for gonococcal conjunctivitis usually involves antibiotics, and it is important to finish all of the medication, even if the symptoms have improved.
1.
Breast Cancer Patients Living Longer Post-Medicaid Expansion
2.
Error on the MGUS-Autoimmune Disease Association.
3.
Patients with chronic myeloid leukemia who take nilotinib are at higher risk for diabetes and hyperlipidemia.
4.
The majority of cancer medications that receive expedited approval end up failing confirmatory trials.
5.
Unified Neuro/Psych Residency Program: New Proposal.
1.
Optimizing Melanoma Treatment: Strategies in Diagnosis, Clinical Research, and Physician Training
2.
Hemoglobin C: Understanding its Role in Sickle Cell Disease
3.
Beyond the Human Eye: How AI Is Redefining Brain Cancer Diagnosis Through Advanced Imaging
4.
Understanding Abemaciclib: A Breakthrough Treatment for Breast Cancer
5.
The Growing Challenge of Haematological Malignancies in Older Adults
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
4.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
5.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation